Searched for
CIPLA NEWS
Parag Parikh Flexi Cap Fund raises stake in ITC, HDFC Bank and 14 other stocks in MayParag Parikh Flexi Cap Fund, India’s largest active flexi-cap scheme by AUM, raised exposure to ITC, HDFC Bank and 14 other stocks in May, ...- Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...
- Geopolitical stability will decide market’s next move: Sandip SabharwalIndian equity markets are holding above 24,000, buoyed by improving sentiment and steady earnings, though geopolitical tensions remain a co...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- Gainers & Losers: NLC India, MCX and Kaynes Technology among 6 big movers on ThursdayDomestic equities rallied for a second day on Thursday, with banks, metals and pharma powering gains even as IT lagged, while several major...
- Cipla shares rally 8% despite 55% YoY slump in Q4 profit. Why Citi, Nuvama, other brokerages hiked targetCipla shares surged on Thursday, extending gains to nearly 11% in two sessions, after several brokerages turned bullish on the stock despit...
- Cipla Q4 Results: Profit falls 55% YoY to Rs 555 crore; co declares Rs 13/sh dividendCipla Ltd announced a significant 55% year-on-year drop in its consolidated net profit for the fourth quarter, reaching Rs 555 crore. This ...
- Stocks in news: Airtel, Tata Motors, Dr Reddy's, NTPC, Dixon TechnologiesMarkets faced selling pressure on Tuesday due to weak global cues and macroeconomic concerns, with the Nifty approaching support at 23,150....
- Q4 earnings, crude oil, FII action among 8 factors to steer D-Street this weekIndian stock markets are set for a busy week. Key events like Q4 earnings announcements for many companies will influence trading. Foreign ...
- Cohance Lifesciences shares skyrocket 20% on hiring former Cipla CEO Umang VohraShares of Cohance Lifesciences surged 20% on Monday after the appointment of former Cipla CEO Umang Vohra as its new Executive Chairman and...
- Ahead of Market: 10 things that will decide stock market action on ThursdayNifty 50 and BSE Sensex declined, snapping a three-day rally due to IT and FMCG losses. Rising India VIX signaled caution, though broader t...
- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
- Tariff threat ain't over yet! Sun Pharma, other pharma stocks plunge up to 6%Pharma stocks fell after reports that the Trump administration may impose tariffs—potentially up to 100%—on drugmakers not ensuring low pri...
- Buy Cipla, target price Rs 1830: Motilal OswalCipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 124555.61 Crore) operating in Pharmaceuticals ...
- Cipla eyes acquisitions, inorganic partnerships in US marketCipla plans acquisitions and inorganic partnerships in the US market while strengthening its presence in the domestic market. The company a...
- Cipla promoters mull stake sale to top PE firms Blackstone, Baring Asia: ReportHowever, the company has issued a clarification, saying that "the company is not aware of any event that requires disclosure under Listing ...
- Cipla to invest 15 million euros in Germany’s Ethris to expand respiratory portfolioThe investment will facilitate a long-term strategic partnership between Cipla and Ethris for development of messenger RNA (mRNA)-based the...
- Cipla skids 4% on Jan-Mar earnings missThe total revenue from operations was Rs 5,260.33 crore, up 14.19 per cent from Rs 4,606.45 crore the company reported in the year-ago quar...
- Q2 takeaways: Will Cipla’s earnings drive the stock further?Its India business grew by 17 per cent YoY with strong growth across the three businesses and continued servicing of patients with Covid-19...
- Stay away from mid-caps for the time being: Abhimanyu Sofat, IIFLThough there is a hope of reduction in taxation and direct tax reforms, the weekend statement is getting a lot of HNI community worried, sa...
Load More
